1. Japan Stocks

  2. •

    Industrials

  3. •

    Staffing & Employment Services
WDB Holdings Co., Ltd.

WDB Holdings Co., Ltd.

2475.T
WDB Holdings Co., Ltd.JP flagTokyo Stock Exchange
1,792.00
JPY
-19.00
- -
34.38BMarket Cap
WDB Holdings Co., Ltd.
2475.T
(Tokyo Stock Exchange)

Recent

price

1,792.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
1,045.8
1,129.89
1,234.43
1,287.41
1,378.57
1,483.5
1,630
1,900.45
2,095.32
2,172.88
2,226.01
2,374.77
2,416.65
2,510.2
2,603.83
- -
- -
Revenue per Share
32.45
46.29
64.89
58.14
75.62
82.45
103.37
168.73
147.31
156.97
171.79
211.32
179.75
180.67
155.36
- -
- -
Basic EPS, GAAP
57.87
5.01
49.53
72.81
115.4
51.78
118.92
170.66
161.41
136.8
206.02
-113.55
164.87
189.41
60.3
- -
- -
Free Cash Flow per Basic Share
5.5
6.23
9.54
7.45
10.93
8.97
9.99
15.61
18.99
24.47
31.49
41.99
50.59
60.02
67.48
- -
- -
Dividend per Share
180.78
221.91
279.17
328.63
388.88
462.33
555.71
710.63
844.52
977
1,118.06
1,292.13
1,423.99
1,548.91
1,636.77
- -
1,673.71
Book Value per Share
177.19
218.38
269.97
334.19
396.37
468.88
565.85
667.81
798.41
974.92
1,112.95
1,298.83
1,441.29
1,578.54
1,685.01
- -
1,728.12
Tangible Book Value per Share
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
- -
20
Basic Weighted Avg Shares
20,911
22,458
24,324
25,479
27,651
29,756
32,694
38,000
41,570
43,108
44,126
46,876
47,602
49,298
51,137
50,305
- -
Sales/Revenue/Turnover
6.07
7.44
8.93
7.93
9.15
9.2
10.44
11.03
11.94
11.5
11.58
13.47
11.57
11.09
9.91
8.87
- -
Operating Margin (%)
165
184
236
235
206
214
213
298
305
331
342
331
272
240
286
359
- -
Depreciation Expense
649
920
1,279
1,151
1,517
1,654
2,073
3,374
2,923
3,114
3,405
4,171
3,541
3,548
3,051
2,755
- -
Net Income, GAAP
47.96
45.26
41.56
44.27
40.06
39.67
37.17
34.72
37.23
36.48
32.77
31.86
31.92
29.87
33.83
35.05
- -
Effective Tax Rate (%)
3.1
4.1
5.26
4.52
5.49
5.56
6.34
8.88
7.03
7.22
7.72
8.9
7.44
7.2
5.97
5.48
- -
Profit Margin (%)
1,082
1,515
2,181
3,075
4,363
5,834
7,152
10,098
12,836
16,246
18,978
16,535
19,171
21,503
20,470
18,284
17,607
Working Capital
382
846
504
102
16
16
13
14
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
3,641
4,441
5,485
6,725
8,030
9,461
11,389
13,799
16,274
19,687
22,303
25,796
28,464
31,151
33,241
34,306
34,028
Total Equity
12.96
14.97
18.03
15.42
17.42
16.31
18.41
19.25
18.46
15.92
14.88
16.36
12.94
12.16
9.84
8.16
- -
Return on Invested Capital (%)
14.77
17.43
20.38
17.54
20.68
19.25
20.28
26.58
18.87
16.98
15.56
16.26
11.99
10.81
8.47
7.37
- -
Return on Capital (%)
20.37
22.93
25.8
19.17
21.21
19.37
20.31
26.61
18.88
17.23
16.39
17.5
13.22
12.14
9.75
8.37
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'25
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
- -
20
Market Capitalization
36,310
33,248
34,112

Working Capital

FRC

•

in mil. unless spec.
Mar'25
Jun'26
Sep'26
Total Current Assets
27,406
- -
24,276
Cash, Cash Equivalents & STI
20,575
- -
17,453
Accounts Receivable, Net
6,446
- -
6,281
Inventories
65
- -
4
Total Current Liabilities
6,936
- -
6,670
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.91%
9.07%
3.2%
Free Cash Flow
-43.82%
-128%
-186.59%
Net Income, GAAP
7.45%
-3.23%
-9.7%
Sales/Revenue/Turnover
5.5%
2.69%
-1.63%
Total Cash Common Dividend
22.32%
15.56%
-5.92%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
12,470
12,185
12,632
12,011
49,298
2025
- -
- -
- -
- -
51,137
2026
- -
- -
- -
- -
50,305

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
31.89
- -
- -
- -
180.67
2025
- -
- -
- -
- -
155.36
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
60.02
2025
- -
- -
- -
- -
67.48
2026
- -
- -
- -
- -
- -
Similar Companies
UT Group Co., Ltd. (2146.T)
Adecco Group AG (AHEXY)
Wilson Learning Worldwide Inc. (9610.T)
Sportsfield Co., Ltd. (7080.T)
Altech Corporation (4641.T)
Heidrick & Struggles International, Inc. (HSII)
Business
WDB Holdings Co., Ltd. (2475.T) serves as a holding company primarily engaged in human resource services, contract research organization (CRO) activities, and platform solutions within the biotechnology, pharmaceutical, chemical, and engineering sectors. The company operates through its subsidiaries to provide temporary staffing, permanent placement, and dispatching services for scientific researchers, engineers, and specialists in biopharma research and development, chemical sectors, and engineering fields; CRO support encompassing safety information management, data management and statistical analysis, consulting, quality control, dossier preparation for product registration, clinical trial support, regulatory affairs, and pharmacovigilance for pharmaceuticals, medical devices, quasi-drugs, cosmetics, food, and feed; platform services including doconico for staffing management and other digital solutions for centralized operations; as well as other offerings such as contracted manufacturing of organic chemicals, M&A and business revitalization support in pharmaceuticals, chemistry, foodstuffs, and engineering, and initiatives promoting employment of the disabled through data processing and related tasks. WDB Holdings maintains operations principally in Japan with Tokyo and Himeji offices, alongside international presence in Europe and the United States via subsidiaries like Oy Medfiles Ltd. for clinical and regulatory services. Founded in 1985 and headquartered at 101 Edomachi, Chuo-ku, Kobe-shi, Hyogo, Japan, the company lists on the Prime Market of the Tokyo Stock Exchange and manages nine group companies employing over 1,000 staff excluding temporary workers. Recent developments include the October 2025 relocation of its head office to Kobe from Himeji; the November 2023 establishment of DOCO1 Co., Ltd. for staffing platform development and operations; the 2023 acquisition and merger of WDB Clinical Research Co., Ltd. into WDB coco Co., Ltd.; a 2022 shift to the Tokyo Stock Exchange Prime Market alongside WDB coco's move to the Growth Market; and ongoing platform digitization efforts in CRO services as part of its transformation into a platform-based business model.